LEO Pharma Announces British Journal of Dermatology Publication of Three Pivotal Ph 3 Trials of …,

LEO Pharma Inc., a global leader in medical dermatology, today announced … Across all three clinical trials, tralokinumab demonstrated a comparable …, LEO Pharma Inc., a global leader in medical dermatology, today announced … Across all three clinical trials, tralokinumab demonstrated a comparable …, Read More